T-cell transduction and culture

The use of genetically modified T cells to target cancer is a promising and evolving field. The two most common approaches revolve around genetically engineering T cells to introduce either a new T-cell receptor (TCR) or a chimeric antigen receptor (CAR). Adoptive T-cell therapy uses a patient's or donor’s T cells for ex vivo genetic modification and expansion for infusion into the patient.

Takara Bio proudly offers a complete suite of tools and services for T-cell transduction, culture, expansion, and analysis.


T-cell related products

Transduction-enhancing reagent that promotes colocalization of lentivirus/retrovirus with target hematopoietic cells.

Chemically defined T-cell culture medium that supports stable growth in the presence or absence of serum.

Monoclonal antibody that specifically reacts with T cell receptor-CD3 complexes on circulating human T cells.

A sterile, closed system for growing T cells that provides reduced risk of both culture contamination and user infection.

10-minute quantitative assays using a smartphone app for IL-2, TNF-α, IFN-γ, and IL-6.


Additional products and services

Use the drop-down menus to choose the appropriate virus product for your experiments.

Takara Bio provides exceptional CMO services to drive clinical research.


Learning resources

RetroNectin reagent enhances transduction efficiency in ACT.

RetroNectin-mediated gene transfer to hematopoietic cells.

Our straightforward protocol boosts naïve T-cell expansion.

An overview of features and benefits and FAQs about LymphoONE T-Cell Expansion Xeno-Free Medium.

Protocol for growing suspension cells in a closed, sterile system using CultiLife 215 Culture Bags.

10-minute quantitation of human cytokines enables streamlined assessment of cultured immune cells.


Overview of RetroNectin reagent

Watch an introductory video and learn how RetroNectin reagent works.

Get details on some of the most commonly asked questions about RetroNectin reagent.

Learn about how research to improve T-cell engineering and expansion contributes to the advancement of T-cell therapies for cancer.